Enrique Poradosu's Trading History
| NVCTNuvectis Pharma | Jan 09, 2026 | Chief Science & Business Off | Uninformative Buy | ― | $33.38M | |
NVCT Insider Shares: 1.81M (7.05%) | ||||||
You May Also Like
Enrique Poradosu insider profile FAQ
What is the percentage of profitable transactions made by Enrique Poradosu?
The percentage of profitable transactions made by Enrique Poradosu is 60%.
What is the average return per transaction made by Enrique Poradosu?
The average return per transaction made by Enrique Poradosu is 16.00%.
What stocks does Enrique Poradosu hold?
Enrique Poradosu holds: NVCT stocks.
What was Enrique Poradosu's most profitable transaction?
Enrique Poradosu’s most profitable transaction was an Informative Buy of NVCT stock on February 8, 2022. The return on the trade was 74.30%.
What is Enrique Poradosu's role in Nuvectis Pharma?
Enrique Poradosu's role in Nuvectis Pharma is Chief Science & Business Off.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.